CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
other : PRFother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03227367
NCT03227367N/ACompleted
CompareCT.gov

Platelet Rich Fibrin/Biphasic Calcium Phosphate Impairs Osteoclasts Differentiation and Promotes Apoptosis by the Intrinsic Mitochondrial Pathway in Chronic Periodontitis

Meenakshi Ammal Dental College and Hospital·interventional·Posted Jul 24, 2017·Updated Jul 26, 2017

In Brief

A clinical study evaluating other : PRF for Periodontal Disease and 2 related conditions. Completed, enrolled 50 participants.

Detailed Summary

The present study is an effort to investigate the hypothesis that Platelet Rich Fibrin/Biphasic Calcium Phosphate may play a role in inhibiting osteoclasts differentiation and in bone loss.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeriodontal Disease, Periodontal Bone Loss, Osteoclastic Bone Loss
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJul 24, 2017
Enrollment StartMar 17, 2014
Primary CompletionApr 13, 2016
Study CompletionMar 18, 2017
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 8.9 years ago

Interventions

other : PRFother

mononuclear cells from the peripheral blood of chronic periodontitis patients were intervened with PRF, BCP and PRF/BCP combination